| Detected | Trial | Change |
|---|---|---|
| 2026-08-08 | NCT07235384 A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in… |
Trial sites expanded: 1 -> 12 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07211776 | A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active… | Thyroid Eye Disease (TED) | Recruiting |
| NCT07218146 | A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed… | Small-cell Lung Cancer | Recruiting |
| Phase 1/2 | |||
| NCT06885281 | A Study of ZL-1310 in Participants With Selected Solid Tumors | Solid Tumors | Recruiting |
| Phase 1 | |||
| NCT06179069 | A Study of ZL-1310 in Subjects With Small Cell Lung Cancer | SCLC | Recruiting |
| NCT07374848 | Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected… | Solid Tumors | Recruiting |
| NCT07235384 | A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in… | Atopic Dermatitis (AD) | Recruiting |
| NCT07658482 | A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in… | Healthy Volunteers | Not Yet Recruiting |